Yayın:
Effects of Lipoprotein-Associated Phospholipase A2 on Arginase/Nitric Oxide Pathway in Hemodialysis Patients

dc.contributor.authorAysegul Tektas
dc.contributor.authorTEMEL, HALİDE EDİP
dc.contributor.authorSema Uslu
dc.contributor.authorAhmet Yalçın
dc.contributor.authorGarip Şahin
dc.contributor.authorGökhan Temïz
dc.contributor.authorMehmet Kara
dc.contributor.authorHalide Edip Temel
dc.contributor.authorEmine Sütken Demirkan
dc.contributor.authorErtuğrul Çolak
dc.contributor.authorÖmer Çolak
dc.contributor.orcid0000-0002-2239-7841
dc.contributor.orcid0000-0002-9708-0988
dc.contributor.orcid0000-0002-5956-2038
dc.contributor.orcid0000-0002-4287-5433
dc.contributor.orcid0000-0002-5233-1165
dc.contributor.orcid0000-0003-3251-1043
dc.contributor.orcid0000-0002-3094-6046
dc.date.accessioned2025-11-13T11:23:53Z
dc.date.issued2012-05-14
dc.identifier.doi10.3109/0886022x.2012.681535
dc.identifier.endpage743
dc.identifier.issn0886-022X
dc.identifier.issue6
dc.identifier.openalexW2128384013
dc.identifier.scopus2-s2.0-84862174254
dc.identifier.startpage738
dc.identifier.urihttps://hdl.handle.net/11421/6658
dc.identifier.urihttps://doi.org/10.3109/0886022x.2012.681535
dc.identifier.volume34
dc.identifier.wos000305013400013
dc.language.isoen
dc.relation.ispartofRenal Failure
dc.rightsopenAccess
dc.subjectArginase
dc.subjectInternal medicine
dc.subjectMedicine
dc.subjectEndocrinology
dc.subjectCreatinine
dc.subjectBody mass index
dc.subjectLipid profile
dc.subjectNitric oxide
dc.subjectNitrite
dc.subjectLipoprotein
dc.subjectAlbumin
dc.subjectDialysis
dc.subjectCholesterol
dc.subjectHemodialysis
dc.subjectAsymmetric dimethylarginine
dc.subjectLipoprotein-associated phospholipase A2
dc.subjectArginine
dc.subjectBiochemistry
dc.subjectChemistry
dc.subjectNitrate
dc.subject.sdg3
dc.titleEffects of Lipoprotein-Associated Phospholipase A2 on Arginase/Nitric Oxide Pathway in Hemodialysis Patients
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5074721002

Dosyalar

Koleksiyonlar